"Urology Associates of Central California (UACC) is the largest urology group in the central valley. Our Fresno urology clinic provides the highest level of comprehensive care ranging from conservative treatment to surgical intervention in every area of urologic care. UACC’s 8 Board Certified urologists and eligible specialists offer a variety of experience and expertise including: Bladder Disorders, Kidney and Urinary Tract Disorders, Stone Disease, Urinary Incontinence in men & women, Prostate Disease/Health, Genitourinary Cancer, Robotic assisted Prostatectomy, Sexual Dysfunction, Pediatric urology, and minimally invasive surgery for urologic diseases. When you're looking for Fresno urology treatment, look no further than UACC."

During the past decade, Urology Associates of Central California conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology Associates of Central California" #1 sponsor was "Abbott" with 3 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Myrexis Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology Associates of Central California" #1 collaborator was "Carolina Urologic Research Center" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Therion Biologics Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Urology Associates of Central California" are "Prostate Cancer" (7 trials), "Cystitis, Interstitial" (2 trials), "Prostatic Neoplasms" (2 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Urology Associates of Central California" in a lesser frequency.

Most popular intervention types in "Urology Associates of Central California" are "Drug" (9 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atrasentan" (2 trials), "Degarelix" (2 trials), "Apaziquone" (1 trials) and "Goserelin acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology Associates of Central California" are 9 trials for "Male" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Urology Associates of Central California". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Urology Associates of Central California, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Urology Associates of Central California, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".